Sunflower Pharmaceutical Group (002737.SZ): Compound polyethylene glycol (3350) electrolyte powder obtained drug registration certificate.

Sunflower Pharmaceutical Group (002737.SZ) announced that its subsidiary has recently received the Drug Registration Certificate issued by the National Medical Products Administration for the electrolyte dispersion of compound polyethylene glycol (3350). After obtaining the Drug Registration Certificate for the electrolyte dispersion of compound polyethylene glycol (3350), the company will accelerate the mass production and market launch of the new product, further expand its product portfolio, optimize its product structure layout, leverage its brand resource advantages, and enhance its market competitiveness.